“Only buy something that you’d be perfectly happy to hold if the market shut down for 10 years.”
— Warren Buffett
A 10-year holding period can reveal far more about an investment than any short stretch of market volatility. For shareholders in Elevance Health Inc (NYSE: ELV), the long-term result has been strong: a $10,000 investment made in October 2016, with dividends reinvested, grew to $36,318.18 by October 2, 2026. That performance highlights the combined effect of share-price appreciation, cash dividends, and compounding through reinvestment.
Elevance Health, formerly known as Anthem, is one of the largest health benefits companies in the United States. Its scale, recurring premium revenue, and established role in managed care have historically made ELV a closely watched name among long-term investors evaluating defensive growth and dividend compounding within the healthcare sector.
ELV 10-Year Return at a Glance
| Start date: | 10/05/2016 |
|
|||
| End date: | 10/02/2026 | ||||
| Start price/share: | $122.07 | ||||
| End price/share: | $386.43 | ||||
| Starting shares: | 81.92 | ||||
| Ending shares: | 94.01 | ||||
| Dividends reinvested/share: | $47.43 | ||||
| Total return: | 263.27% | ||||
| Average annual return: | 13.77% | ||||
| Starting investment: | $10,000.00 | ||||
| Ending investment: | $36,318.18 | ||||
The headline figure is straightforward: ELV delivered a 263.27% total return over the period, equivalent to a 13.77% annualized return. In practical terms, the original investment more than tripled over a decade. Those results were computed using the Dividend Channel DRIP Returns Calculator, assuming dividends were reinvested.
How Dividends Contributed to ELV’s Total Return
Share-price appreciation was the main driver of the gain, with the stock rising from $122.07 to $386.43 over the measurement period. But dividends also added meaningfully to the outcome. Elevance Health paid a cumulative $47.43 per share in dividends over the decade, and reinvestment increased the share count from 81.92 shares to 94.01 shares.
That increase in share count is a useful reminder that total return is not the same as price return. Price return captures only the stock’s change in market value. Total return captures both market appreciation and cash distributions, along with the compounding effect of putting those distributions back to work.
- Stock price growth from $122.07 to $386.43 per share
- $47.43 per share in dividends paid over the period
- Dividend reinvestment, which increased the number of shares owned
- Compounding over a full 10-year holding period
Current Dividend Yield and Yield on Cost
Based on the most recent annualized dividend rate of $6.88 per share, ELV has a current yield of approximately 1.78% using the ending share price shown above. For current buyers, that is the relevant starting income yield at today’s market price.
For long-term holders, yield on cost offers a different perspective. Using the same $6.88 annualized dividend and the original purchase price of $122.07, the yield on cost works out to 5.64%. That metric illustrates how a growing dividend stream can become more meaningful over time relative to the initial capital committed.
What the 10-Year ELV Return Suggests
Several features stand out in this return profile. First, a relatively modest starting dividend yield did not prevent strong total returns. Second, reinvestment mattered even though ELV was not a high-yield stock. Third, most of the wealth creation came from the business generating earnings growth that was ultimately reflected in a higher share price.
That combination is common among successful long-term compounders: the dividend supports total return, but the core driver is durable business performance. In ELV’s case, investors were effectively rewarded for owning a large, established managed-care company through a full cycle rather than reacting to shorter-term market swings.
As always with historical return analysis, the point is not that the next decade will necessarily resemble the last one. The more useful takeaway is that long holding periods can materially change outcomes when a company combines business durability, capital returns to shareholders, and the mathematics of reinvestment.
“Value investing is at its core the marriage of a contrarian streak and a calculator.” — Seth Klarman
